Vulnerability Description
Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication channel to send and receive system status and operational data. This could allow an attacker that has circumvented network security measures to view sensitive non-private data or to perform a man-in-the-middle attack.
CVSS Score
CRITICAL
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Baxter | Sigma Spectrum Infusion System Firmware | >= 6.0, <= 6.05 |
| Baxter | Sigma Spectrum Infusion System | - |
Related Weaknesses (CWE)
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-04Third Party AdvisoryUS Government Resource
- https://www.us-cert.gov/ics/advisories/icsma-20-170-04Third Party AdvisoryUS Government Resource
FAQ
What is CVE-2020-12040?
CVE-2020-12040 is a vulnerability with a CVSS score of 9.8 (CRITICAL). Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication ch...
How severe is CVE-2020-12040?
CVE-2020-12040 has been rated CRITICAL with a CVSS base score of 9.8/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2020-12040?
Check the references section above for vendor advisories and patch information. Affected products include: Baxter Sigma Spectrum Infusion System Firmware, Baxter Sigma Spectrum Infusion System.